LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro.

For the last 38 years, all neuroprotective agents for patients with ischemic stroke have failed in clinical trials. The innate immune system, particularly microglia, is a much-discussed target for neuroprotective agents. Promising results for neuroprotection by inhibition of integrins with drugs suc...

Full description

Saved in:
Bibliographic Details
Main Authors: Robin Jansen, Marc Pawlitzki, Michael Gliem, Sven G Meuth, Stefanie Schreiber, Michael-W Görtler, Jens Neumann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0314020
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533197987348480
author Robin Jansen
Marc Pawlitzki
Michael Gliem
Sven G Meuth
Stefanie Schreiber
Michael-W Görtler
Jens Neumann
author_facet Robin Jansen
Marc Pawlitzki
Michael Gliem
Sven G Meuth
Stefanie Schreiber
Michael-W Görtler
Jens Neumann
author_sort Robin Jansen
collection DOAJ
description For the last 38 years, all neuroprotective agents for patients with ischemic stroke have failed in clinical trials. The innate immune system, particularly microglia, is a much-discussed target for neuroprotective agents. Promising results for neuroprotection by inhibition of integrins with drugs such as natalizumab in animal stroke models have not been translated into clinical practice. Our present study reveals the relevance of a β2 integrin, lymphocyte function-associated antigen-1 (LFA-1), as a potential key player in protecting neuronal cell death after oxygen-glucose deprivation in organotypic hippocampal cell cultures. In addition, we identified microglial cells as effector cells for LFA-1-mediated neuroprotection. The counterpart of LFA-1 on microglia is unclear, but we show strong expression of ICAM-5 in hippocampal neurons, suggesting a critical role for direct crosstalk between microglia and neurons for neuronal survival under oxygen-glucose deprivation. The enigma of neuroprotection after ischemic stroke remains to be solved, and our findings highlight the continuing importance and lack of understanding of integrin-mediated pathways after ischemic stroke and the need for further intensive research.
format Article
id doaj-art-d78f19483934458eba8b92b5d3307dda
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-d78f19483934458eba8b92b5d3307dda2025-01-17T05:31:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031402010.1371/journal.pone.0314020LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro.Robin JansenMarc PawlitzkiMichael GliemSven G MeuthStefanie SchreiberMichael-W GörtlerJens NeumannFor the last 38 years, all neuroprotective agents for patients with ischemic stroke have failed in clinical trials. The innate immune system, particularly microglia, is a much-discussed target for neuroprotective agents. Promising results for neuroprotection by inhibition of integrins with drugs such as natalizumab in animal stroke models have not been translated into clinical practice. Our present study reveals the relevance of a β2 integrin, lymphocyte function-associated antigen-1 (LFA-1), as a potential key player in protecting neuronal cell death after oxygen-glucose deprivation in organotypic hippocampal cell cultures. In addition, we identified microglial cells as effector cells for LFA-1-mediated neuroprotection. The counterpart of LFA-1 on microglia is unclear, but we show strong expression of ICAM-5 in hippocampal neurons, suggesting a critical role for direct crosstalk between microglia and neurons for neuronal survival under oxygen-glucose deprivation. The enigma of neuroprotection after ischemic stroke remains to be solved, and our findings highlight the continuing importance and lack of understanding of integrin-mediated pathways after ischemic stroke and the need for further intensive research.https://doi.org/10.1371/journal.pone.0314020
spellingShingle Robin Jansen
Marc Pawlitzki
Michael Gliem
Sven G Meuth
Stefanie Schreiber
Michael-W Görtler
Jens Neumann
LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro.
PLoS ONE
title LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro.
title_full LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro.
title_fullStr LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro.
title_full_unstemmed LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro.
title_short LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro.
title_sort lfa 1 a potential key player in microglia mediated neuroprotection against oxygen glucose deprivation in vitro
url https://doi.org/10.1371/journal.pone.0314020
work_keys_str_mv AT robinjansen lfa1apotentialkeyplayerinmicrogliamediatedneuroprotectionagainstoxygenglucosedeprivationinvitro
AT marcpawlitzki lfa1apotentialkeyplayerinmicrogliamediatedneuroprotectionagainstoxygenglucosedeprivationinvitro
AT michaelgliem lfa1apotentialkeyplayerinmicrogliamediatedneuroprotectionagainstoxygenglucosedeprivationinvitro
AT svengmeuth lfa1apotentialkeyplayerinmicrogliamediatedneuroprotectionagainstoxygenglucosedeprivationinvitro
AT stefanieschreiber lfa1apotentialkeyplayerinmicrogliamediatedneuroprotectionagainstoxygenglucosedeprivationinvitro
AT michaelwgortler lfa1apotentialkeyplayerinmicrogliamediatedneuroprotectionagainstoxygenglucosedeprivationinvitro
AT jensneumann lfa1apotentialkeyplayerinmicrogliamediatedneuroprotectionagainstoxygenglucosedeprivationinvitro